Clinical Trials Browser

Uterine Cervical Neoplasms

NCT07450183 2026-03-04

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

Phase 2 Not yet recruiting

33 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07423611 2026-02-20

RACE

Phase 2 Not yet recruiting

388 enrolled

Breast

Breast Neoplasms

NCT02662504 2026-02-05

MesoPDT

Phase 2 Completed

6 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma

NCT04567420 2025-10-16

DARE

Phase 2 Recruiting

70 enrolled

Breast

Breast Neoplasms

NCT00766142 2025-08-29

COCHISE

Phase 2 Terminated

18 enrolled 9 charts

GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04747145 2025-08-21

Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma

Phase 2 Active not recruiting

38 enrolled

CNS

Glioblastoma

NCT07089199 2025-07-28

TitAN

Phase 2 Not yet recruiting

34 enrolled

Thoracic

NSCLC

NCT07067268 2025-07-16

Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy

Phase 2 Recruiting

76 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT00354393 2025-07-15

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Phase 2 Completed

9 enrolled

Other solid neoplasmThoracic

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT06914440 2025-07-15

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

Phase 2 Recruiting

27 enrolled

Breast

Breast Neoplasms

NCT06953882 2025-07-14

SELECT

Phase 2 Recruiting

140 enrolled

Breast

HER2 Negative Breast Cancer

NCT06646445 2025-06-13

PREMICES

Phase 2 Not yet recruiting

60 enrolled

Gastrointestinal

Turcot syndrome, Colonic Neoplasms, Microsatellite Instability

NCT04517214 2025-04-02

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma

Phase 2 Active not recruiting

100 enrolled

Head & Neck

Nasopharyngeal Carcinoma

Clinical Trials

ACCRAPAN

Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1

RACE

MesoPDT

DARE

COCHISE

Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma

TitAN

Tislelizumab Combined With Capecitabine for Nasopharyngeal Carcinoma With Residual EBV DNA After Radiotherapy

Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

SELECT

PREMICES

Comparing Chemotherapy With/Without Toripalimab For Primary Metastatic Nasopharyngeal Carcinoma